In the presence of heart hypertrophy, Sirt3 results overexpressed causing an increase of MAPK/ERK, PI3K/Akt and Ras pathway activity, as well as an intracellular increase in ROS levels. The gene discussed is SIRT3; the disease is cardiac hypertrophy.